According to the latest market research study published by P&S Intelligence, the AI-based clinical trials solution market was valued at about $1,327 million in 2021, which will grow at a rate of over 20%, to reach about $7,074 million by 2030. Phase II Clinical Trials Most Demanded The phase II category dominated the industry, with a revenue share of 51%, … Continua a leggere→